BK Virus Infection: Clinical Trials

2 trials for BK Virus Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Terminated 2
Phase 21Terminated 1

Follow BK Virus Infection: new trials by email Literature Review of BK Virus Infection trials Research Report on BK Virus Infection

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant
Posoleucel (ALVR105), Placebo - Adenovirus Infection, BK Virus Infection
Phase 2 / Phase 3TerminatedAlloVir4512022-03-242024-05-16
Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC)
Posoleucel (ALVR105), Placebo - BK Virus Infection, Hemorrhagic Cystitis
Phase 3TerminatedAlloVir972021-03-182024-05-14

Narrower conditions

Adenoviridae Infections (1)  ·  Cystitis, Hemorrhagic (1)  ·  Cytomegalovirus Infections (1)  ·  Epstein-Barr Virus Infections (1)

Broader conditions

Cystitis (1)  ·  DNA Virus Infections (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Herpesviridae Infections (1)  ·  Infections (1)  ·  Male Urogenital Diseases (1)  ·  Tumor Virus Infections (1)  ·  Urinary Bladder Diseases (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)  ·  Virus Diseases (1)

Sponsors

AlloVir (2)

Countries

France (2)  ·  Italy (2)  ·  South Korea (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  United States (2)  ·  Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  Sweden (1)  ·  Turkey (Türkiye) (1)

Results publications

PMID 38597860